BRAF and neoplasm: Regarding molecular features, patients with KIAA1549-BRAF fusion have better outcomes, especially when the tumor is cerebellar, and those with FGFR1 mutations—especially those with FGFR1 pK656E point mutation—do worse, although the last study included a small number of both pediatric and adult LGGs [58].